IMMUNMODULATORISCHE VERBINDUNGEN
European patent · EP3658522 · In force
Register entry
- Publication number
- EP3658522
- Application number
- EP18837877
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jul 27, 2018
- Published
- Jun 3, 2020
- Granted
- Dec 22, 2021
- Protection ends at the latest
- Jul 26, 2038
- Next annual fee due
- Jul 31, 2027
- IPC classes
- C07C 15/24 (2006.01)A61K 31/015 (2006.01)A61P 37/02 (2006.01)
- Priority
- US 201762538123 P 28.07.2017
- PCT application
- PCT/US2018/044088 27.07.2018
- PCT publication
- WO2019/023575 31.01.2019
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Aug 1, 2026
Next annual fee due on
- Next annual fee due on
- 31.07.2026 → 31.07.2027
Published in Swissreg on 01.08.2026
- Aug 1, 2025
Next annual fee due on
- Next annual fee due on
- 31.07.2025 → 31.07.2026
Published in Swissreg on 01.08.2025
- Aug 1, 2024
Change
Published in Swissreg on 01.08.2024
- Aug 1, 2023
Change
Published in Swissreg on 01.08.2023
- Nov 2, 2022
Change
Published in Swissreg on 02.11.2022
- Aug 1, 2022
Change
Published in Swissreg on 01.08.2022
- Feb 24, 2022
Agent entered
- Representative
- Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich
Published in Swissreg on 24.02.2022
- Dec 22, 2021
Granted
Published in Swissreg on 22.12.2021
Parties
Inventor
Sunnyvale California 94085, US
San Francisco California 94121, US
Palo Alto California 94303, US
Sunnyvale California 94089, US
El Cerrito California 94530, US
Palo Alto California 94306, US
Foster City California 94404, US
Cupertino California 95014, US
Sunnyvale California 94085, US
Belmont California 94002, US
Mountain View California 94043, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.